Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie R Field

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|February 18, 2010
Transmembrane domain 6 of the human serotonin transporter contributes to an aqueously accessible binding pocket for serotonin and the psychostimulant 3,4-methylene dioxymethamphetamineJulie R Field, L Keith Henry, Randy D Blakely
Trends in Molecular Medicine|September 30, 2011
Targeting glutamate synapses in schizophreniaJulie R Field, Adam G Walker, P Jeffrey Conn
Cellular and Molecular Neurobiology|May 26, 2006
Dopamine signaling architecture in Caenorhabditis elegansPaul W McDonald, Tammy Jessen, Julie R Field, et al.
ACS Chemical Neuroscience|July 11, 2012
Y95 and E444 interaction required for high-affinity S-citalopram binding in the human serotonin transporterSteven Combs, Kristian Kaufmann, Julie R Field, et al.
Personalized Medicine|December 5, 2015
Clinician Perspectives on Using Pharmacogenomics in Clinical PracticeKim M Unertl, Habiba Jaffa, Julie R Field, et al.
Proteins|August 16, 2008
Structural determinants of species-selective substrate recognition in human and Drosophila serotonin transporters revealed through computational docking studiesKristian W Kaufmann, Eric S Dawson, L Keith Henry, et al.
The Journal of Biological Chemistry|November 8, 2005
Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressantsL Keith Henry, Julie R Field, Erika M Adkins, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 7, 2013
Electronic health record design and implementation for pharmacogenomics: a local perspectiveJosh F Peterson, Erica Bowton, Julie R Field, et al.
Journal of Clinical Epidemiology|December 3, 2015
A prognostic model based on readily available clinical data enriched a pre-emptive pharmacogenetic testing programJonathan S Schildcrout, Yaping Shi, Ioana Danciu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2011
Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporterBrent J Thompson, Tammy Jessen, L K Henry, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|February 18, 2010
Transmembrane domain 6 of the human serotonin transporter contributes to an aqueously accessible binding pocket for serotonin and the psychostimulant 3,4-methylene dioxymethamphetamineJulie R Field, L Keith Henry, Randy D Blakely
Trends in Molecular Medicine|September 30, 2011
Targeting glutamate synapses in schizophreniaJulie R Field, Adam G Walker, P Jeffrey Conn
Cellular and Molecular Neurobiology|May 26, 2006
Dopamine signaling architecture in Caenorhabditis elegansPaul W McDonald, Tammy Jessen, Julie R Field, et al.
ACS Chemical Neuroscience|July 11, 2012
Y95 and E444 interaction required for high-affinity S-citalopram binding in the human serotonin transporterSteven Combs, Kristian Kaufmann, Julie R Field, et al.
Personalized Medicine|December 5, 2015
Clinician Perspectives on Using Pharmacogenomics in Clinical PracticeKim M Unertl, Habiba Jaffa, Julie R Field, et al.
Proteins|August 16, 2008
Structural determinants of species-selective substrate recognition in human and Drosophila serotonin transporters revealed through computational docking studiesKristian W Kaufmann, Eric S Dawson, L Keith Henry, et al.
The Journal of Biological Chemistry|November 8, 2005
Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressantsL Keith Henry, Julie R Field, Erika M Adkins, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 7, 2013
Electronic health record design and implementation for pharmacogenomics: a local perspectiveJosh F Peterson, Erica Bowton, Julie R Field, et al.
Journal of Clinical Epidemiology|December 3, 2015
A prognostic model based on readily available clinical data enriched a pre-emptive pharmacogenetic testing programJonathan S Schildcrout, Yaping Shi, Ioana Danciu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2011
Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporterBrent J Thompson, Tammy Jessen, L K Henry, et al.
Pageof 2